Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL708957

CC(C)Oc1ccc(OCc2ccncc2)cc1-c1nc2cccnc2[nH]1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.36
PPARG P37231 3/20 0.36
ALOX5 P09917 1/20 0.36
PSEN1 P49768 1/20 0.36
GPR132 Q9UNW8 4/20 0.36
PDE4B Q07343 1/20 0.36
DHODH Q02127 1/20 0.36
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
LRRK2 Q5S007 2/20 0.35
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
TBK1 Q9UHD2 1/20 0.35
KDM1A O60341 1/20 0.34
RCOR1 Q9UKL0 1/20 0.34
SLC2A1 P11166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL711385 0.95 CYP3A4 (0.39) MAOBGPR132PPARDPPARALRRK2
Trifluoroacetic Acid SCHEMBL710197 0.93 MAOB (0.36) MAOBPPARGALOX5PSEN1GPR132
Trifluoroacetic Acid SCHEMBL711107 0.93 GPR132 (0.43) PPARGALOX5PSEN1GPR132DHODH
SCHEMBL9071892 0.91 CYP3A4 (0.37) PDE4BDHODHKDM1ARCOR1
Trifluoroacetic Acid SCHEMBL710214 0.90 PDE4A (0.40) PPARGPDE4B
Trifluoroacetic Acid SCHEMBL711950 0.88 CYP3A4 (0.39) MAOBPDE4BPPARDPPARA
Trifluoroacetic Acid SCHEMBL712435 0.87 SMO (0.40) MAOBPPARGLRRK2
SCHEMBL711187 0.87 CYP3A4 (0.46) MAOBALOX5PDE4BLRRK2
Trifluoroacetic Acid SCHEMBL709554 0.86 CYP3A4 (0.43) MAOBPPARGALOX5PSEN1GPR132
Trifluoroacetic Acid SCHEMBL709188 0.85 GCK (0.39) MAOBGPR132PDE4BDHODHPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK MAOB 1046/4885PPARG 991/4885ALOX5 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.